Correlation Between 4Front Ventures and Takeda Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both 4Front Ventures and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4Front Ventures and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4Front Ventures Corp and Takeda Pharmaceutical Co, you can compare the effects of market volatilities on 4Front Ventures and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4Front Ventures with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4Front Ventures and Takeda Pharmaceutical.
Diversification Opportunities for 4Front Ventures and Takeda Pharmaceutical
0.55 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between 4Front and Takeda is 0.55. Overlapping area represents the amount of risk that can be diversified away by holding 4Front Ventures Corp and Takeda Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and 4Front Ventures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4Front Ventures Corp are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of 4Front Ventures i.e., 4Front Ventures and Takeda Pharmaceutical go up and down completely randomly.
Pair Corralation between 4Front Ventures and Takeda Pharmaceutical
Assuming the 90 days horizon 4Front Ventures Corp is expected to under-perform the Takeda Pharmaceutical. In addition to that, 4Front Ventures is 3.77 times more volatile than Takeda Pharmaceutical Co. It trades about -0.11 of its total potential returns per unit of risk. Takeda Pharmaceutical Co is currently generating about 0.0 per unit of volatility. If you would invest 2,664 in Takeda Pharmaceutical Co on September 14, 2024 and sell it today you would lose (81.00) from holding Takeda Pharmaceutical Co or give up 3.04% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
4Front Ventures Corp vs. Takeda Pharmaceutical Co
Performance |
Timeline |
4Front Ventures Corp |
Takeda Pharmaceutical |
4Front Ventures and Takeda Pharmaceutical Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with 4Front Ventures and Takeda Pharmaceutical
The main advantage of trading using opposite 4Front Ventures and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4Front Ventures position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.4Front Ventures vs. Goodness Growth Holdings | 4Front Ventures vs. Body and Mind | 4Front Ventures vs. Rubicon Organics | 4Front Ventures vs. CLS Holdings USA |
Takeda Pharmaceutical vs. 4Front Ventures Corp | Takeda Pharmaceutical vs. Khiron Life Sciences | Takeda Pharmaceutical vs. BellRock Brands | Takeda Pharmaceutical vs. Elixinol Global |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |